RO-262198

N/A

Report date: 2024/12/05 15:15:11

Base Information

Drug NameRO-262198
Drug Alias NameBXL-219BXL-2198BXL-698Ro-2198Ro-26-2198 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor modulatorsNuclear factor NF-kappa-B complex modulators
TargetsVitamin D receptorNuclear factor NF-kappa-B complex
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioxell SPABioxell Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioxell SPABioxell Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A